CompaniesByCap
MCK
McKesson Corporation (MCK)
NYSE · Healthcare

McKesson Corporation Revenue 2008–2026

McKesson Corporation annual/quarterly revenue history and growth rate from 2008 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.

  • McKesson Corporation revenue for the quarter ending December 31, 2025 was 106.2 B, a 11.40% increase year-over-year.
  • McKesson Corporation revenue for the twelve months ending December 31, 2025 was 402.4 B, a 21.56% increase year-over-year.
  • McKesson Corporation annual revenue for 2026 was 403.4 B, a 12.36% increase from 2025.
  • McKesson Corporation annual revenue for 2025 was 359.1 B, a 16.22% increase from 2024.
  • McKesson Corporation annual revenue for 2024 was 309.0 B, a 11.65% increase from 2023.
  • McKesson Corporation annual revenue for 2023 was 276.7 B.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %

McKesson Corporation (MCK) — Frequently Asked Questions

McKesson Corporation (MCK) is a publicly traded US company in the Healthcare sector. It has a market capitalization of $97.69B. In fiscal 2026 it reported revenue of $403.43B and net income of $4.76B. Explore MCK's stock price, financial statements, earnings history, margins and key ratios below.

What is McKesson Corporation's market cap?

McKesson Corporation (MCK) has a market capitalization of $97.69B.

What is the MCK stock price?

MCK trades at $787.19 (-0.41% on the day).

How much revenue does McKesson Corporation make?

McKesson Corporation reported revenue of $403.43B in fiscal 2026.

Is MCK profitable?

In fiscal 2026, McKesson Corporation reported net income of $4.76B.